CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.
Saved in:
| Title: | CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL. |
|---|---|
| Authors: | Alduaij W; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Jiang A; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Villa D; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Collinge B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Boyle M; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Meissner B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Hilton LK; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Farinha P; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Slack GW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Craig JW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology, University of Virginia Health System, Charlottesville, VA., Gerrie AS; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Freeman CL; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Steidl C; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Sehn LH; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Savage KJ; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. |
| Source: | Blood [Blood] 2025 Feb 06; Vol. 145 (6), pp. 590-596. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39441916 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alduaij+W%22">Alduaij W</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Jiang+A%22">Jiang A</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Villa+D%22">Villa D</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Collinge+B%22">Collinge B</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Ben-Neriah+S%22">Ben-Neriah S</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Boyle+M%22">Boyle M</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Meissner+B%22">Meissner B</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Hilton+LK%22">Hilton LK</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Farinha+P%22">Farinha P</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Slack+GW%22">Slack GW</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Craig+JW%22">Craig JW</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology, University of Virginia Health System, Charlottesville, VA.<br /><searchLink fieldCode="AU" term="%22Gerrie+AS%22">Gerrie AS</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Mungall+AJ%22">Mungall AJ</searchLink>; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Steidl+C%22">Steidl C</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Sehn+LH%22">Sehn LH</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Scott+DW%22">Scott DW</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Savage+KJ%22">Savage KJ</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Feb 06; Vol. 145 (6), pp. 590-596. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39441916 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2024025725 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 590 Titles: – TitleFull: CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alduaij W – PersonEntity: Name: NameFull: Jiang A – PersonEntity: Name: NameFull: Villa D – PersonEntity: Name: NameFull: Collinge B – PersonEntity: Name: NameFull: Ben-Neriah S – PersonEntity: Name: NameFull: Boyle M – PersonEntity: Name: NameFull: Meissner B – PersonEntity: Name: NameFull: Hilton LK – PersonEntity: Name: NameFull: Farinha P – PersonEntity: Name: NameFull: Slack GW – PersonEntity: Name: NameFull: Craig JW – PersonEntity: Name: NameFull: Gerrie AS – PersonEntity: Name: NameFull: Freeman CL – PersonEntity: Name: NameFull: Mungall AJ – PersonEntity: Name: NameFull: Steidl C – PersonEntity: Name: NameFull: Sehn LH – PersonEntity: Name: NameFull: Scott DW – PersonEntity: Name: NameFull: Savage KJ IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 02 Text: 2025 Feb 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 145 – Type: issue Value: 6 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |